Fort Lee, New Jersey, USA, Dec. 4, 2014 (GLOBE NEWSWIRE) -- Herborium® Group,
Inc.(OTC Pink: HBRM),
www.Herborium.com, a
Botanical Therapeutics® Company providing unique, all
botanical medicines (Botanical Therapeutics®), announced today that
its Black Friday and Cyber Monday sales results grew 80% over the
same sales events in 2013.
The two 24 hour sales events, known as Black Friday and Cyber
Monday, drew unprecedented sales from the USA, Canada and Europe,
not only exceeded 2013 sales but maintained the company's healthy
margin.
The recent sales results continue to surpass Herborium's 2013
performance confirming expectations for 2014 yearly results.
Total Sales for the three quarters of 2014 are 31% higher than the
total sales for the year ending 2013, third quarter 2014 gross
profit margin increased 80% over the same period during 2013.
"The Company growth in the USA and abroad continues.
Herborium will be announcing new sales initiatives commencing
in 2014. We look forward to a very successful end of 2014 and
to the future growth and profitability of our novel, all natural
medicines - Botanical Therapeutics®". Commented Dr. Agnes P.
Olszewski, CEO and Chairwoman of Herborium Group.
About Herborium Group, Inc.
Herborium Group, Inc., a botanical therapeutics® company that
develops, license and markets proprietary, botanical based
medicinal products to consumers and healthcare professionals. The
Company business model focuses on emerging market opportunities
spearheaded by the growth of a new market sector located between
high-cost, high-risk, ethical pharmaceuticals and commoditized
classic nutraceuticals (supplements). The Company uses
clinical validation and a proactive regulatory strategy based on
the FDA Guidance for Industry: Botanical Drug Products
(FDA Guidance 2004) to establish and maintain a
differential advantage. Herborium has secured a pipeline of
botanical ingredients based products in the areas of dermatological
needs, wellness and energy, prostate health, women's health and
selected sexual disorders resulting from cardiovascular disease,
use of anti-depressants, diabetes, surgical procedures, and other
problems. Herborium Group sells its products in the United States,
the United Kingdom, and continental Europe through a network of
distributors, specialty retailers, and e-commerce. For more
information, please visit www.herborium.com, and www.acnease.com.
Safe Harbor Statement: This release contains
forward-looking statements with respect to the results of
operations and business of Sunrise Consulting Group, Inc., which
involves risks and uncertainties. The Company's actual future
results could materially differ from those discussed. The
Company intends that such statements about the Company's future
expectations, including future revenues and earnings, and all other
forward looking statements be subject to the "Safe Harbors"
provision of the Private Securities Litigation Reform Act of
1995.
CONTACT: Contact Information:
Herborium Group, Inc.
Email: InvestorsRelations@Herborium.com